ArticleCureus2025
The Use of Porous Titanium Metal Augments for Acetabular Defects in Total Hip Arthroplasty: Initial Results From a Single-Center Experience.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Catastrophic Acetabular Osteolysis and Component Migration Secondary to Surgical Cup Malpositioning: A Case Report.Cureus · 2026Article
- Harnessing 3D Printing Technology for Complex Acetabular Reconstruction in Revision Total Hip Arthroplasty: From Childhood Hip Trauma to Customized Modern Solutions.Journal of orthopaedic case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective One of the major challenges that orthopaedic surgeons face during revision total hip arthroplasty (THA) is the presence of acetabular bone defects. Nowadays, preference is given to metal augments when it comes to segmental, uncontained defects. This study aimed to present the previous experience at our hospital in the use of porous metal augments for bony defects of the acetabulum. Methods Our retrospective observational study included a total of 30 patients who underwent revision or primary THA with the use of porous metal acetabular augmentation between 2021 and 2024. The extent and localization of acetabular bone defects were assessed on preoperative X-ray series and CT scans, confirmed intraoperatively, and classified using the Paprosky classification. The functional status of the patients was evaluated using the Modified Harris Hip Score (mHHS). The complications were defined as adverse outcomes requiring rehospitalization and further treatment. Statistical data analysis was performed using SPSS Statistics version 28.0 (IBM Corp., Armonk, NY). Results Surgeries were performed by 14 different orthopaedic surgeons, using a posterolateral hip approach in all cases. Pinnacle Multihole® cementless acetabular shell and Gription® TF augment (DePuy Synthes, Raynham, MA) were implanted in all patients. Revision of the acetabular component was indicated due to mechanical complications in 19 patients (64%), and periprosthetic infection in nine (30%) patients. In two cases (6%) metal augment was used in primary hip arthroplasty. As for acetabular defects, Paprosky type IIb defect was observed in nine cases (30%), type IIc in five cases (16%), type IIIa in 12 (40%), and type IIIb defect in four cases (14%). The analysis of mHHS showed a significant improvement after the operative treatment and the completion of the rehabilitation. Complications of surgical treatment were observed in five patients (16%). Conclusions Based on our findings, the use of metal augments is a reliable surgical method that enables the surgeon to deal with various defects of the acetabulum bone mass, ensuring the establishment of favourable biomechanical conditions in the hip joint.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.